A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease (AMBAR)
This study is ongoing, but not recruiting participants.
Instituto Grifols, S.A.
First Posted: March 22, 2012
Last Update Posted: August 2, 2017
Grifols Biologicals Inc.
Information provided by (Responsible Party):
Grifols Biologicals Inc. ( Instituto Grifols, S.A. )
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||December 2017|
|Estimated Primary Completion Date:||December 2017 (Final data collection date for primary outcome measure)|